Thu.Apr 18, 2024

article thumbnail

Myeloma Expert: Earlier Use of Bispecifics Can Improve Patient Outcomes

Drug Topics

As the potential grows to use emerging bispecifics in earlier lines of myeloma therapy, so does the potential to induce better patient outcomes, said Kirollos Hanna, PharmD.

232
232
article thumbnail

Covid ignited a global controversy over what is an airborne disease. The WHO just expanded its definition

STAT

In the chaotic first few months of the Covid-19 pandemic, stores faced shortages of all kinds — toilet paper, canned food, and especially, cleaning supplies. With everyone scrubbing their groceries, mail, even library books, good luck finding antibacterial wipes or disinfectant sprays back then. That’s because public health advice in early 2020 focused on sanitizing surfaces, not protecting against a virus that could be spread through the air.

145
145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Peer Recovery Support May Benefit Patients in Emergency Departments for Opioid Overdose

Drug Topics

Patients in ED being treated for an opioid overdose were more likely to initiate medication for opioid use disorder after discharge when they received peer recovery support services.

199
199
article thumbnail

Opinion: Former HHS secretaries: Congress should adopt site-neutral payments for health care

STAT

As two former secretaries of Health and Human Services, we are all too familiar with the struggle of finding narrow openings for bipartisanship. Despite our different approaches, we believe that addressing health care costs is a truly bipartisan issue. To be serious about creating access for people to the best possible care, that care must be affordable for patients and taxpayers.

145
145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Pharmacies Should Adopt Proactive Health, Wellness to Help Patients

Drug Topics

Kathy Campbell, PharmD, discusses why she believes wellness and proactive health are the future of pharmacy and the unique value they offer compared to traditional models.

196
196
article thumbnail

STAT+: Dana-Farber retracts string of studies in systematic review of data integrity

STAT

An ongoing investigation into data integrity at Dana-Farber Cancer Institute has resulted in a string of retractions, the latest of which is a 2006 Science paper co-authored by institute president and CEO Laurie Glimcher. The retraction notice, published in Science on Thursday, noted that the authors had become aware of discrepancies in key scientific images that led them to lose confidence in key figures in the study, although the study’s lead author opposed the retraction.

144
144

More Trending

article thumbnail

STAT+: Microsoft is selling AI in health care, and helping to set its standards. Is that a problem?

STAT

For a company moving as quickly as possible to build artificial intelligence into everything — including health care — Microsoft spends a lot of time talking about how to regulate it. The tech giant has helped organize four separate coalitions to devise guidelines and technical standards for AI in health care. It supplies these groups — composed of health systems, government regulators, and other health businesses — with top executives to serve on steering committees,

Hospitals 142
article thumbnail

RSV Vaccine Could Prevent Increased Risk of Disease Among Individuals Aged 18 to 59

Pharmacy Times

The results displayed well tolerability and safety with Abrysvo, meeting the study’s co-primary endpoint of immunogenicity and primary safety

Vaccines 149
article thumbnail

STAT+: Animal rights group urges SEC to investigate Charles River over monkey purchases

STAT

A leading animal rights group has asked securities regulators to investigate Charles River Laboratories for allegedly misleading investors about its sales and purchases of long-tailed macaques, which are widely used in clinical research by pharmaceutical companies and universities, among others. The company, one of the largest clinical research organizations, was accused of failing to disclose purchases of thousands of non-human primates that should not have been imported into the U.S. and obtai

article thumbnail

Novo Nordisk attracts lawmakers' scrutiny after dropping discounted insulin product Levemir

Fierce Pharma

Novo Nordisk is receiving pushback from a trio of lawmakers over its decision to discontinue its long-acting insulin product Levemir, which was due for a steep discount at the start of the new year | Novo Nordisk is receiving pushback from a trio of lawmakers on its decision to discontinue its long-acting insulin product Levemir, which was due for a steep discount at the start of the new year.

134
134
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

STAT+: Cancer vaccine startup launches with $54 million, Spark veteran as CEO

STAT

A new startup focused on creating vaccines for cancers, influenza, and potentially even HIV launched Thursday with $54 million in funding. Corner Therapeutics’ Series A round was led by Ziff Capital Partners, a little-known family office started by billionaire Dirk Ziff. The biotech is also being led by Spark Therapeutics co-founder Steven Altschuler, who joined Ziff Capital in 2018 as its managing director of health care ventures.

Vaccines 131
article thumbnail

Federal agencies open online portal for reporting anticompetitive practices in healthcare

Fierce Healthcare

Federal agencies want to hear from the public about monopolistic and anticompetitive behavior within the healthcare industry. | FTC, DOJ and HHS said that information and accounts received from the public could plant the seeds for formal investigations into healthcare companies' monopolistic or anticompetitive practices.

130
130
article thumbnail

STAT+: 23andme CEO Anne Wojcicki moves to take company private

STAT

After a tumultuous experience on the public markets, 23andMe CEO Anne Wojcicki is moving to take the company private. Wojcicki disclosed her plans in a filing with the Securities and Exchange Commission late Wednesday, saying that she intends to seek out potential partners and financiers to help. Wojcicki currently holds 49.99% of the voting power in the company, according to the Wall Street Journal, which first reported on the plan.

131
131
article thumbnail

Making Residency Research Projects Patient Centered: How Retrospective Research Can Significantly Impact Cancer Care

Pharmacy Times

Through recognizing the importance of research in the scope of pharmacy practice by national pharmacy organizations, research can become a prominent role and responsibility of pharmacy.

123
123
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

STAT+: Cerevel drug for Parkinson’s disease improved symptom control in trial

STAT

Cerevel Therapeutics, a neuroscience biotech that AbbVie is acquiring , reported that its drug for Parkinson’s disease improved motor symptom control as an add-on therapy in a late-stage trial. The 27-week study found that patients taking the drug, tavapadon, on top of a common Parkinson’s treatment called levodopa, experienced   1.7 hours of improvement in “on time” without dyskinesia, which is the amount of time patients function well without involuntary m

126
126
article thumbnail

3 takeaways on the new federal data privacy proposal after its first public showcase

Fierce Healthcare

At the House Energy and Commerce’s data privacy hearing April 17, lawmakers discussed for the first time Chair Cathy McMorris Rodgers’ discussion draft of a new federal data privacy bill, the Ameri | House lawmakers revived discussions of a national data privacy law at an Energy & Commerce hearing Wednesday. Here are the key takeaways.

128
128
article thumbnail

STAT+: ARCH, Medicines Co. veterans raise $290 million for in-licensed obesity drugs

STAT

After scouring 200 companies’ pipelines — including a few overlooked pharma shelves — a new company backed by investment firm Population Health Partners and ARCH Venture Partners is launching with one of the most wide-ranging pipelines yet for obesity drug development. Metsera came out of stealth mode Thursday with $290 million in seed and Series A financing.

125
125
article thumbnail

Tirzepatide Demonstrates Reduction in Sleep Apnea-Relate Events

Pharmacy Times

Eli Lilly and Company will submit results of the study to support tirzepatide (Zepbound) for treatment of obstructive sleep apnea later this year.

132
132
article thumbnail

Opinion: Medicaid should cover donor breast milk for vulnerable infants

STAT

Each day, more than 1,000 babies are born prematurely in America. Born before 37 weeks and often weighing less than five pounds, these infants are at greater risk for a suite of serious health problems, including life-threatening infections, chronic lung disease, blindness, and death. One of the leading causes of death is necrotizing enterocolitis. An inflammatory disease of the gut, necrotizing enterocolitis can kill up to 40% of the smallest — and most vulnerable — babies.

123
123
article thumbnail

How Differences in Bispecific Therapies Impact Myeloma Treatment Operations

Drug Topics

According to Kirollos Hanna, PharmD, although similarities exist between bispecific therapies in the myeloma space, health care providers should take special note of practical differences and nuances associated with each when operationalizing them at their site of care.

98
article thumbnail

STAT+: Elevance’s private equity deal will form $4 billion primary care company

STAT

These days, the surefire way to get ahead in health insurance is to become a health care provider, and Elevance just upped the ante. It’s joining with private equity to launch a $4 billion primary care company. Elevance leaders divulged more about the company’s venture with Clayton, Dubilier & Rice on its first quarter earnings call Thursday.

Insurance 120
article thumbnail

Predictions for AI in mental health in the coming year

pharmaphorum

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomes Dr Carl Marci, chief psychiatrist and managing director of mental health and neuroscience at OM1 to discuss predictions for AI in mental health in the coming year, as well as what might truly make a difference in the field and lessen the mental health crisis.

121
121
article thumbnail

Middletown Pharmacy and Wellness Staff Care for the Community

Pharmacy Times

Tara Schneider, PharmD, and her husband, Chuck Schneider, MBA, offer expanded clinical services in their Louisville, Kentucky, pharmacy.

132
132
article thumbnail

Sanofi, busy with cost-savings campaign, restructures US commercial vaccine group

Fierce Pharma

During a busy period of overhaul at Sanofi, the company is restructuring its U.S. vaccine commercial group. | During a busy period of overhaul at Sanofi, the company is restructuring its U.S. vaccine commercial group. A spokesperson said the company would offer affected employees a chance to apply for new roles, plus "outplacement services.

Vaccines 121
article thumbnail

Climate Change Increases Rate of Infectious Diseases, Expert Says

Pharmacy Times

Speaker Monica Diaz describes the detrimental impact climate change has on the transmission and increases in infectious disease cases.

132
132
article thumbnail

STAT+: How BIO CEO’s cozy relationship with WuXi soured

STAT

WASHINGTON — In the photo, the two men are grinning widely: the CEO of WuXi Biologics and the incoming CEO of the biotechnology industry’s largest trade group. The photo, posted to WuXi’s LinkedIn page , shows the pair in a firm, congratulatory glad hand over John Crowley’s appointment to lead the Biotechnology Innovation Organization.

114
114
article thumbnail

Durvalumab With Chemotherapy Shows Long-Term Overall Survival at 3 Years

Pharmacy Times

The results were the longest survival follow-up ever reported for a phase 3 trial for biliary tract cancer.

article thumbnail

Interview: Thermo Fisher Scientific's Sarah Englert on opening the doors to its new innovation hub

Outsourcing Pharma

Yesterday, Thermo Fisher Scientific opened its first Innovation Lab in Center Valley, Pennsylvania., as a space where partners can come together to collaborate, innovate, and ideate on solutions to the biggest clinical supply chain pain points.

116
116
article thumbnail

Omnichannel odyssey: Trends redefining marketing in 2024

pharmaphorum

Embark on an omnichannel marketing odyssey by exploring the top trends reshaping the industry in 2024. Discover how chatbots, video content, and interactivity are transforming marketing strategies.

114
114
article thumbnail

Outrun Therapeutics announces launch with $10m seed funding

Pharmaceutical Technology

Outrun Therapeutics announced its launch with $10m seed funding to advance a protein stabilisation pipeline focused on E3 ligase inhibitors.

129
129
article thumbnail

Health Care Affordability in the Election Spotlight

Drug Topics

More than half of those who responded to a recent KFF survey say they are worried about paying for their prescription drugs.

112
112
article thumbnail

Amgen CEO nabs pay raise thanks to Horizon deal. Does that incentivize aggressive M&A?

Fierce Pharma

Amgen CEO Robert Bradway scored a 5.8% increase in overall compensation last year mostly thanks to the company’s acquisition of Horizon Therapeutics. | Amgen CEO Robert Bradway scored a 5.8% increase in overall compensation last year mostly thanks to the company's acquisition of Horizon Therapeutics.

115
115
article thumbnail

Heart disease risk ‘calculator’ could save lives

pharmaphorum

UK researchers describe an algorithm that is more accurate than current tools at predicting an individual’s risk of developing cardiovascular disease in the next 10 years.

110
110
article thumbnail

Shinobi strikes deal with electronics powerhouse Panasonic to create new cell therapy manufacturing platform

Fierce Pharma

History is coming full circle as induced pluripotent stem (iPS) cell-derived cell therapy maker Shinobi Therapeutics links up with Panasonic and Japan’s Kyoto University, where the first mouse iPS | Shinobi Therapeutics has entered an accord with electronics powerhouse Panasonic and Kyoto University in a bid to develop a new closed-system manufacturing device for cheaper and more efficient production of cell therapies.

115
115